BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 37119603)

  • 21. Human papillomavirus infections among women with cervical lesions and cervical cancer in Yueyang, China: a cross-sectional study of 3674 women from 2019 to 2022.
    Zeng M; Zhang X; He L; Liu X; Liu H; Deng R; Qiu B; Liu F; Xiao H; Li Q; Li W; Liu C; Ge Y
    Virol J; 2023 Nov; 20(1):254. PubMed ID: 37919730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV genotype prevalence and distribution during 2009-2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination.
    Wang J; Tang D; Wang K; Wang J; Zhang Z; Chen Y; Zhang X; Ma C
    BMC Womens Health; 2019 Jul; 19(1):90. PubMed ID: 31286939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
    PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and genotype distribution of human papillomavirus infection among women in Jingzhou, China: a population-based study of 51,720 women.
    Liu S; Mei B; Ouyang Y; Li C
    Virol J; 2023 Dec; 20(1):297. PubMed ID: 38102627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the Prevalence and Quantification of viral load of different human papillomavirus types in Turkish women population.
    Tekkesın N; Goktas S; Alkis V; Koc S; Gurbuz T; Goktas P
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4347-4355. PubMed ID: 36580019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The distribution and pathogenic risk of non-9-valent vaccine covered HPV subtypes in cervical lesions.
    Ma M; Zhu J; Yang Y; Wang X; Jin Y; Zhang J; Wu S
    Cancer Med; 2022 Mar; 11(6):1542-1552. PubMed ID: 34981653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
    J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and genotype distribution of human papillomavirus infection among female outpatients in Northeast China: a population-based survey of 110,927 women.
    Zhang H; Zhang S
    Arch Gynecol Obstet; 2023 Jul; 308(1):35-41. PubMed ID: 35904609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Marembo T; Dube Mandishora R; Borok M
    Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPV prevalence and genotype distribution in 2,306 patients with cervical squamous cell carcinoma in central and eastern China.
    Han C; Huang W; Ye M; Zou R; Lan J; Chen J; Jiang J; Wang H; Xia L; Luo J; Li D; Geng J; Wang Z; Huang J
    Front Public Health; 2023; 11():1225652. PubMed ID: 37701907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of 14 High-risk Human Papillomavirus (HPV) Genotypes Within the Italian Cervical Cancer Screening.
    Cenci M; Rossi F; Pisani T
    In Vivo; 2023; 37(5):2161-2165. PubMed ID: 37652482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of human papillomavirus infection among women with cervical cytological abnormalities in the Zhoupu District, Shanghai City, China, 2014-2019.
    Li P; Liu Q; Li W; Liu Z; Xing B; Wu S; Zhou Z; Sun L; Ren H; Li H; Li H
    Virol J; 2021 Mar; 18(1):51. PubMed ID: 33685499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and carcinogenic risk of high-risk human papillomavirus subtypes in different cervical cytology: a study of 124,251 cases from the largest academic center in China.
    Tao X; Zhang H; Wang S; Chen T; Cong Q; Wang L; Zhou X; Zhao C
    J Am Soc Cytopathol; 2021; 10(4):391-398. PubMed ID: 33906830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
    Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
    Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening.
    Donkoh ET; Asmah RH; Agyemang-Yeboah F; Dabo EO; Wiredu EK
    Cancer Control; 2022; 29():10732748221094721. PubMed ID: 35536890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023.
    Yao X; Li Q; Chen Y; Du Z; Huang Y; Zhou Y; Zhang J; Wang W; Zhang L; Xie J; Xu C; Ge Y; Zhou Y
    Front Public Health; 2024; 12():1332696. PubMed ID: 38590815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and distribution of human papillomavirus genotypes among women with high-grade squamous intraepithelial lesion and invasive cervical cancer in Ganzhou, China.
    Liao L; Cheng H; Zeng F; Zhou W; Ding Y
    J Clin Lab Anal; 2019 Mar; 33(3):e22708. PubMed ID: 30390349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
    Ali MAM; Bedair RN; Abd El Atti RM
    Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-risk human papillomavirus genotypes in cervical lesions and vaccination challenges in China.
    Xu QX; Zhang ZY
    Asian Pac J Cancer Prev; 2015; 16(6):2193-7. PubMed ID: 25824736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.